Shannon Thyme Klinger - 27 Aug 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Legal Officer
Signature: /s/ James Dillon, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 27 Aug 2025
Net transactions value: -$13,290
Form type: 4
Filing time: 29 Aug 2025, 16:10:00 UTC
Previous filing: 09 Jun 2025
Next filing: 02 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Klinger Shannon Thyme	Chief Legal Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, as Attorney-in-Fact	29 Aug 2025	0001866132

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+774	+2.8%		28,257	27 Aug 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$9,274	-375	-1.3%	$24.73	27,882	27 Aug 2025	Direct	F2
transaction	MRNA	Common Stock	Options Exercise		+329	+1.2%		28,211	28 Aug 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$4,016	-160	-0.57%	$25.10	28,051	28 Aug 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-774	-9.1%	$0.000000	7,736	27 Aug 2025	Common Stock	774		Direct	F1, F3
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-329	-14%	$0.000000	1,973	28 Aug 2025	Common Stock	329		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4	25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.